Sure Regular Antiperspirant Deodorant Aerosol Recalled for Benzene Contamination
Sure Regular Antiperspirant Deodorant Aerosol (6 oz cans) sold nationwide in the US and Canada is being recalled due to benzene contamination. All lots expiring on or before August 2023 are affected.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This FDA Class I recall receives a Severe (4) score. The agency's own FDA Class I classification mandates a minimum severity of 4 per the rubric, and no deaths or serious injuries have been reported that would elevate it to Critical (5).
Plain-English summary
Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), sold in 6 oz (170 g) aerosol cans, is being recalled. The recall is due to the presence of benzene, a chemical contaminant. The product is manufactured by TCP HRB ACQUISITON LLC and distributed by Idelle Labs, Ltd., El Paso, TX.
Approximately 5.4 million units have been distributed nationwide in the United States and Canada. All lots with expiration dates on or before August 2023 are included in this recall.
This is an FDA Class I recall, the agency's most serious classification for drug recalls, indicating a potentially serious health hazard.
The recalled product
- Product
- Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5518-06
- Manufacturer
- TCP HRB ACQUISITON LLC
- Category
- Drug — Antiperspirant Deodorant
- Hazard
- benzene
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- All lots
- expiry on or before August 2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27